Zantac’s Developer Settles Lawsuits Claiming Cancer Linknews2024-10-10T00:05:33+00:00October 10th, 2024|The New York Times|
Johnson & Johnson Proposes $6.5 Billion in New Talc Settlement Offernews2024-05-02T03:25:19+00:00May 2nd, 2024|The New York Times|
Monsanto Should Pay $857 Million in PCB Case, Jury Findsnews2023-12-19T02:53:57+00:00December 19th, 2023|The New York Times|
Years After Monsanto Deal, Bayer’s Roundup Bills Keep Piling Upnews2023-12-06T11:59:57+00:00December 6th, 2023|The New York Times|
Kroger Agrees to Pay $1.2 Billion to Settle Opioid Claimsnews2023-09-08T18:18:48+00:00September 8th, 2023|The New York Times|
Mallinckrodt’s Bankruptcy Plan Would Cut Payments to Opioid Victims by $1 Billionnews2023-08-23T20:33:07+00:00August 23rd, 2023|The New York Times|
Opioid Settlement Money Is Being Spent on Police Cars and Overtimenews2023-08-15T00:03:26+00:00August 15th, 2023|The New York Times|
Gilead Wins Key Patent Rights Suit Over HIV Prevention Drug PrEPnews2023-05-09T17:34:57+00:00May 9th, 2023|The New York Times|
Johnson & Johnson Reaches Deal for $8.9 Billion Talc Settlementnews2023-04-05T01:25:02+00:00April 5th, 2023|The New York Times|
Biogen Agrees to Pay $900 Million to Settle Lawsuit Over Kickbacksnews2022-09-27T00:35:45+00:00September 27th, 2022|The New York Times|
